These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15523696)

  • 1. Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years.
    Slade MJ; Singh A; Smith BM; Tripuraneni G; Hall E; Peckitt C; Fox S; Graham H; Lüchtenborg M; Sinnett HD; Cross NC; Coombes RC
    Int J Cancer; 2005 Mar; 114(1):94-100. PubMed ID: 15523696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer.
    Benoy IH; Elst H; Philips M; Wuyts H; Van Dam P; Scharpé S; Van Marck E; Vermeulen PB; Dirix LY
    Clin Breast Cancer; 2006 Jun; 7(2):146-52. PubMed ID: 16800974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy.
    Becker S; Becker-Pergola G; Wallwiener D; Solomayer EF; Fehm T
    Breast Cancer Res Treat; 2006 May; 97(1):91-6. PubMed ID: 16319975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer.
    Slade MJ; Smith BM; Sinnett HD; Cross NC; Coombes RC
    J Clin Oncol; 1999 Mar; 17(3):870-9. PubMed ID: 10071278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial quantitative PCR analysis of bone marrow samples from breast cancer patients to monitor systemic micrometastases.
    Shammas FV; Deak E; Nysted A; van Eekelen JA; Osland A; Heikkilä R
    Anticancer Res; 2001; 21(3C):2099-106. PubMed ID: 11501832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of occult bone marrow micrometastases of breast cancer detected by quantitative polymerase chain reaction for cytokeratin 19 mRNA.
    Ikeda N; Miyoshi Y; Motomura K; Inaji H; Koyama H; Noguchi S
    Jpn J Cancer Res; 2000 Sep; 91(9):918-24. PubMed ID: 11011120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of cancer cells disseminated in bone marrow using real-time quantitative RT-PCR of CEA, CK19, and CK20 mRNA in patients with gastric cancer.
    Fujita Y; Terashima M; Hoshino Y; Ohtani S; Kashimura S; Kanzaki N; Osuka F; Kogure M; Gotoh M
    Gastric Cancer; 2006; 9(4):308-14. PubMed ID: 17235634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive detection of micrometastases in bone marrow from patients with breast cancer using immunomagnetic isolation of tumor cells in combination with reverse transcriptase/polymerase chain reaction for cytokeratin-19.
    Zhong XY; Kaul S; Lin YS; Eichler A; Bastert G
    J Cancer Res Clin Oncol; 2000 Apr; 126(4):212-8. PubMed ID: 10782894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CK19 mRNA expression in the bone marrow of patients with esophageal squamous cell carcinoma and its clinical significance.
    Zhang X; Chen SB; Chen JX; Wen J; Yang H; Xie MR; Zhang Y; Hu YZ; Lin P
    Dis Esophagus; 2010 Jul; 23(5):437-43. PubMed ID: 20095997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.
    Benoy IH; Salgado R; Elst H; Van Dam P; Weyler J; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
    Breast Cancer Res; 2005; 7(2):R210-9. PubMed ID: 15743502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.
    Bozionellou V; Mavroudis D; Perraki M; Papadopoulos S; Apostolaki S; Stathopoulos E; Stathopoulou A; Lianidou E; Georgoulias V
    Clin Cancer Res; 2004 Dec; 10(24):8185-94. PubMed ID: 15623593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite alterations plasma DNA of primary breast cancer patients.
    Shaw JA; Smith BM; Walsh T; Johnson S; Primrose L; Slade MJ; Walker RA; Coombes RC
    Clin Cancer Res; 2000 Mar; 6(3):1119-24. PubMed ID: 10741742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19.
    Schoenfeld A; Kruger KH; Gomm J; Sinnett HD; Gazet JC; Sacks N; Bender HG; Luqmani Y; Coombes RC
    Eur J Cancer; 1997 May; 33(6):854-61. PubMed ID: 9291805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.
    Datta YH; Adams PT; Drobyski WR; Ethier SP; Terry VH; Roth MS
    J Clin Oncol; 1994 Mar; 12(3):475-82. PubMed ID: 7509852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.
    Tjensvoll K; Oltedal S; Farmen RK; Shammas FV; Heikkilä R; Kvaløy JT; Gilje B; Smaaland R; Nordgård O
    Clin Breast Cancer; 2010 Oct; 10(5):378-84. PubMed ID: 20920982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow cytokeratin 19 mRNA level is an independent predictor of relapse-free survival in operable breast cancer patients.
    Farmen RK; Nordgård O; Gilje B; Shammas FV; Kvaløy JT; Oltedal S; Heikkilä R
    Breast Cancer Res Treat; 2008 Mar; 108(2):251-8. PubMed ID: 17492378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular detection of disseminated breast cancer cells in the bone marrow of early breast cancer patients using quantitative RT PCR for CEA.
    Janku F; Srovnal J; Korinkova G; Novotny J; Petruzelka L; Power D; Matous B; Hajduch M
    Neoplasma; 2008; 55(4):317-22. PubMed ID: 18505343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer.
    Daskalaki A; Agelaki S; Perraki M; Apostolaki S; Xenidis N; Stathopoulos E; Kontopodis E; Hatzidaki D; Mavroudis D; Georgoulias V
    Br J Cancer; 2009 Aug; 101(4):589-97. PubMed ID: 19623181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal residual disease in gastric cancer: evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow.
    Heiss MM; Simon EH; Beyer BC; Gruetzner KU; Tarabichi A; Babic R; Schildberg FW; Allgayer H
    J Clin Oncol; 2002 Apr; 20(8):2005-16. PubMed ID: 11956259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques.
    Smith BM; Slade MJ; English J; Graham H; Lüchtenborg M; Sinnett HD; Cross NC; Coombes RC
    J Clin Oncol; 2000 Apr; 18(7):1432-9. PubMed ID: 10735890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.